AXON SEC Filings

Axon Enterprise, Inc. (AXON) held its 2026 Annual Meeting of Shareholders on May 28, 2026, with a strong turnout of approximately 90.5% of outstanding shares represented. The meeting confirmed the election of all nine director nominees for the upcoming year, with each nominee receiving a substantial majority of the votes cast. This indicates continued shareholder confidence in the current board leadership and governance structure. Furthermore, shareholders overwhelmingly approved the "Say-on-Pay" proposal, a non-binding advisory vote on executive compensation, signifying shareholder alignment with the company's compensation practices. The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2026 was also ratified with near-unanimous support. These outcomes suggest a stable and supportive shareholder base for Axon's operational and strategic direction.

Axon Enterprise, Inc. reported strong revenue growth of 33.7% to $807.3 million for the first quarter of 2026 compared to the prior year period. This top-line expansion was driven by robust performance across both its Connected Devices segment (up 32.8%) and Software and Services segment (up 34.9%). The company successfully transitioned from an operating loss in the prior year's quarter to an operating income of $29.2 million. Net income also saw a significant increase, rising to $169.3 million from $88.0 million in the same quarter last year, with diluted EPS growing to $2.05 from $1.08. The company made a substantial strategic acquisition of Carbyne Ltd. for $549.7 million, funded by existing cash and investments, which contributed to a significant decrease in cash and cash equivalents. While gross margins saw a slight compression due to tariffs and a higher mix of Platform Solutions revenue, the overall financial performance demonstrates continued strong execution and market demand for Axon's integrated technology solutions.

Axon Enterprise, Inc. (AXON) has filed an 8-K on May 6, 2026, to report its financial results for the first quarter ended March 31, 2026. The filing primarily consists of a shareholder letter (Exhibit 99.1) detailing the company's performance. While specific financial figures are not detailed within the 8-K text itself, investors should refer to the attached shareholder letter for comprehensive insights into revenue, profitability, and any forward-looking statements. This report serves as the official notification of the Q1 2026 results. Investors seeking detailed operational and financial condition updates should carefully review Exhibit 99.1. The company's disclosure emphasizes that this information is furnished and not deemed 'filed' for certain regulatory purposes, which is standard for earnings release disclosures.

Axon Enterprise, Inc. (AXON) announced that Matthew McBrady will not be standing for re-election as a director at the upcoming 2026 Annual Meeting of Shareholders. Mr. McBrady will continue to serve until the end of his current term at the meeting. Importantly, his decision is stated to be unrelated to any disagreements with the Company regarding its operations, policies, or practices, which mitigates concerns about internal disputes or governance issues. Investors should note that while Mr. McBrady's departure is a change in board composition, the company has indicated it was his personal decision regarding re-election. The Board expressed gratitude for his service, highlighting his contributions to the company's growth and progress. This announcement does not appear to signal any immediate operational or strategic shifts but represents a transition in the Board's membership.

Axon Enterprise, Inc. (AXON) announced that director Julie Anne Cullivan will not stand for re-election at the upcoming 2026 Annual Meeting of Shareholders. Ms. Cullivan's tenure will conclude at the meeting, and her decision is stated to be voluntary, without any disagreements with the Company regarding its operations, policies, or practices. The Board of Directors has expressed gratitude for her significant contributions to the Company's growth and leadership during her service. This announcement, filed on March 11, 2026, relates to a change in the composition of the Board. Investors should note that while Ms. Cullivan's departure is amicable, any changes in board leadership can sometimes signal shifts in strategic focus or governance. However, given the information provided, the impact is primarily a procedural one related to board refreshment.

Axon Enterprise, Inc. reported strong revenue growth in the fiscal year ending December 31, 2025, with net sales increasing by 33.5% to $2.8 billion. This growth was driven by robust performance in both the Connected Devices segment (up 29.1%) and the Software and Services segment (up 39.6%). Despite the top-line growth, the company experienced a loss from operations of $62.1 million in 2025, a decrease from the $58.5 million income from operations in the prior year. This shift was largely attributed to a significant increase in operating expenses, primarily due to higher headcount to support growth and increased stock-based compensation expenses. Financially, Axon bolstered its liquidity position, ending the year with $1.2 billion in cash and cash equivalents, a substantial increase driven by proceeds from debt and equity offerings. The company also completed several strategic acquisitions, including Prepared and Dedrone, further strengthening its product ecosystem. However, a material weakness in internal control over financial reporting related to revenue recognition was identified, though remediation efforts are underway. Investors should note the company's ongoing investment in research and development, which represents a significant portion of operating expenses, reflecting a commitment to innovation.

Axon Enterprise, Inc. (AXON) filed an 8-K on February 24, 2026, to report its financial results for the fourth quarter and full fiscal year ended December 31, 2025. The accompanying shareholder letter (Exhibit 99.1) contains the detailed financial performance and outlook. Investors should refer to this exhibit for specific revenue figures, profitability metrics, and any forward-looking statements regarding the company's performance in the upcoming year. The filing is procedural, primarily serving to incorporate the shareholder letter into public record. While the 8-K itself doesn't contain the numerical results, it directs investors to the official shareholder letter for the most crucial financial information. This includes insights into the drivers of revenue growth, any significant cost impacts, and management's commentary on market conditions affecting Axon's business segments, such as TASER, Cloud, and Artificial Intelligence solutions.

Axon Enterprise, Inc. (AXON) announced in an 8-K filing dated February 13, 2026, the complete redemption and conversion of its 0.50% convertible senior notes due 2027. This action effectively retires all outstanding convertible notes, simplifying the company's capital structure. The company utilized cash for the redemption and also settled a significant portion of the notes through a combination of cash and stock, demonstrating a strategic approach to managing its debt obligations.

Axon Enterprise, Inc. has announced the full redemption of its 0.50% convertible senior notes due 2027, with a redemption date set for February 10, 2026. This action will see the company repurchase all outstanding notes at their principal amount plus accrued interest. Investors holding these notes are provided a limited window to convert them into Axon's common stock before the conversion deadline of February 6, 2026. The company also disclosed a Market Disruption Event on January 29, 2026, which has extended the observation period for calculating the conversion settlement value. This extension means the observation period will now conclude on February 9, 2026, and settlement for converted notes is expected on February 11, 2026. This event will impact the exact amount of cash and stock shareholders will receive upon conversion.

Axon Enterprise, Inc. has announced its intention to redeem all outstanding 0.50% convertible senior notes due 2027 on February 10, 2026. The redemption price will be 100% of the principal amount plus accrued and unpaid interest. This action signals a proactive approach by Axon to manage its debt obligations, potentially to reduce future interest expenses or optimize its capital structure. Investors holding these notes should be aware of the redemption timeline and their option to convert their notes into Axon common stock before February 6, 2026. The conversion settlement amount will be determined based on a 30-trading day observation period, providing a mechanism for shareholders to benefit from potential stock appreciation prior to conversion. The redemption of these notes is a significant event that could impact the company's balance sheet and future financial flexibility.

Axon Enterprise, Inc. (AXON) has filed an 8-K report detailing the closing of privately negotiated exchange transactions involving its 0.50% Convertible Senior Notes due 2027. These transactions allowed certain holders to exchange a significant principal amount of Notes for a combination of cash and Axon's common stock. This exchange effectively reduces the company's outstanding convertible debt and increases its outstanding share count, which are key considerations for investors assessing the company's capital structure and potential dilution.

Axon Enterprise, Inc. (AXON) has announced its entry into privately negotiated Exchange Agreements with certain holders of its 0.50% convertible senior notes due 2027. These agreements will facilitate the exchange of approximately $177.9 million in aggregate principal amount of these notes for a combination of cash and newly issued Axon common stock. The exact number of shares to be issued will be determined based on a one-day volume-weighted average price (VWAP) on December 10, 2025, with an estimated issuance of 468,000 shares assuming a hypothetical VWAP of $550.95. This transaction is expected to reduce the outstanding principal amount of the convertible notes to approximately $100.1 million upon closing, anticipated around December 16, 2025. The company is utilizing an exemption under Section 4(a)(2) of the Securities Act for the issuance of these shares, requiring holders to be accredited and qualified institutional buyers. Investors should note that the unwinding of hedging positions by some noteholders could potentially lead to increased volatility in Axon's stock price around the closing date.

Axon Enterprise, Inc. (AXON) reported its financial results for the period ending September 30, 2025. The company experienced a significant increase in net sales, up 30.6% year-over-year for the third quarter, reaching $710.6 million. This growth was driven by strong performance in both its Connected Devices segment (up 23.6%) and its Software and Services segment (up 41.1%). However, the company reported a net loss of $2.2 million for the quarter, a reversal from the $67.0 million net income in the prior year period. This shift was influenced by increased operating expenses, particularly in Research & Development and Selling, General & Administrative, and a higher effective tax rate, partly due to the enactment of the 'One Big Beautiful Bill Act' (OBBBA) impacting R&D tax credits. Despite the quarterly net loss, the year-to-date (nine months ended September 30, 2025) performance shows a net income of $121.9 million, albeit lower than the $241.9 million in the same period last year. The company's balance sheet reflects a robust increase in cash and cash equivalents to $1.4 billion from $454.8 million, supported by strong financing activities including the issuance of $1.75 billion in Senior Notes and proceeds from an at-the-market equity offering. Management believes current liquidity sources are sufficient to meet anticipated cash requirements for at least the next 12 months.

Axon Enterprise, Inc. (AXON) filed an 8-K on November 4, 2025, to report its financial results for the quarter ended September 30, 2025, through a shareholder letter. While the 8-K itself doesn't contain detailed financials, it references an attached Exhibit 99.1, which investors should consult for specific performance metrics, revenue figures, and profitability. This filing indicates that the company is providing its quarterly update as per standard disclosure requirements.

Axon Enterprise, Inc. announced a strategic addition to its Board of Directors with the appointment of Todd Morgenfeld, effective August 28, 2025. Mr. Morgenfeld brings extensive financial and operational leadership experience, having previously held key executive roles at Pinterest, Inc. and Twitter, Inc., as well as serving as a CFO/COO. His appointment, which increases the Board size to eleven members, signifies the company's ongoing commitment to robust governance and financial oversight. Mr. Morgenfeld's expertise is expected to be a valuable asset as Axon continues its growth trajectory and navigates complex capital markets. Mr. Morgenfeld's compensation package is structured to align with market practices for independent directors, including initial and annual restricted stock units and cash retainers for his committee memberships. These arrangements are consistent with the company's existing director compensation program. The company has also entered into a standard indemnification agreement with Mr. Morgenfeld. His background, including experience at Silver Lake Partners and Goldman Sachs, as well as his service on other public company boards, underscores his suitability for this role and his potential to contribute significantly to Axon's strategic decision-making.

Axon Enterprise, Inc. reported strong revenue growth for the second quarter of 2025, with net sales increasing by 32.8% year-over-year to $668.5 million. This growth was driven by robust performance in both the Connected Devices segment (up 28.6%) and the Software and Services segment (up 38.8%). Despite the top-line growth, the company reported a net loss from operations of $1.0 million for the quarter, a decrease from an income of $33.8 million in the prior year, primarily due to a significant increase in operating expenses, particularly in selling, general, and administrative costs driven by higher stock-based compensation and increased headcount. Financially, Axon bolstered its liquidity position significantly, with cash and cash equivalents increasing by $160.7 million to $615.5 million, and total available-for-sale investments growing by $1.1 billion to $1.5 billion, largely following the issuance of $1.75 billion in Senior Notes in March 2025. The company also experienced a substantial increase in financing cash flows due to these note issuances and ATM equity offerings. While revenue growth is positive, investors should monitor the increasing operating expenses and the impact of stock-based compensation, alongside the company's substantial debt load.

Axon Enterprise, Inc. (AXON) filed an 8-K on August 4, 2025, to disclose its financial results for the quarter ended June 30, 2025, via a shareholder letter. While the 8-K itself does not contain detailed financial figures, it serves as an official notification that the company has released its quarterly performance. Investors should refer to the attached Exhibit 99.1, the full shareholder letter, for comprehensive data on revenue, profitability, segment performance, and forward-looking guidance. This filing is crucial for understanding the company's recent operational and financial trajectory.

Axon Enterprise, Inc. (AXON) filed an 8-K on June 2, 2025, reporting the results of its 2025 Annual Meeting of Shareholders held on May 29, 2025. A significant majority of outstanding shares, approximately 89.8%, were represented at the meeting, indicating strong shareholder engagement. All director nominees were overwhelmingly elected, reflecting continued confidence in the company's leadership and strategic direction. The advisory vote on executive compensation ('Say-on-Pay') also passed, albeit with a more divided vote compared to the director elections, suggesting that while shareholders generally approve of compensation practices, there is a notable segment expressing dissent. Furthermore, the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2025 was ratified with near unanimous support, underscoring shareholder trust in the company's financial oversight.

Axon Enterprise, Inc. (AXON) has filed an 8-K report on May 7, 2025, primarily addressing a restatement of previously issued financial statements. The company's Audit Committee, in consultation with management, determined that its audited consolidated financial statements for the fiscal year ended December 31, 2024, and unaudited condensed consolidated financial statements for the quarters ended March 31, 2024, and September 30, 2024, should no longer be relied upon due to an error in the balance sheet presentation of its 0.50% convertible senior notes due 2027. The error involved the misclassification of these notes, amounting to $690.0 million, from current liabilities to long-term liabilities on the balance sheet. This reclassification is due to the notes becoming convertible at the option of holders during the applicable subsequent calendar quarters because the company's stock price met certain thresholds. Importantly, Axon states that this reclassification does not impact total assets, total liabilities, equity, or the statements of operations, cash flows, or equity. The company plans to amend its Form 10-K for the fiscal year ended December 31, 2024, to reflect these restated financials.

Axon Enterprise, Inc. (AXON) reported a strong top-line performance in its first quarter of 2025, with net sales increasing by 31.3% year-over-year to $603.6 million. This growth was driven by robust performance in both the Connected Devices and Software & Services segments. Despite the revenue increase, the company reported a net loss from operations of $8.8 million, a shift from income in the prior year, largely due to significant increases in operating expenses, particularly in selling, general, and administrative (SG&A) and research and development (R&D), driven by higher stock-based compensation and headcount expansion. The company also highlighted substantial gains from strategic investments ($167.3 million) which contributed significantly to its net income of $88.0 million.

Axon Enterprise, Inc. reported strong revenue growth of 33.4% to $2.1 billion for the year ended December 31, 2024. This growth was driven by significant increases in both the TASER segment and the Software and Sensors segment, with notable contributions from TASER device and cartridge sales, as well as Axon Evidence and cloud services. Despite the revenue increase, the company's income from operations decreased to $58.5 million from $156.9 million in the prior year, primarily due to a substantial rise in operating expenses, particularly stock-based compensation and professional/consulting fees related to acquisitions. The company also disclosed two material weaknesses in its internal controls over financial reporting: one related to revenue recognition and another concerning the balance sheet presentation of its convertible senior notes. These weaknesses have led to restatements of prior financial periods. Axon continues to invest heavily in research and development, with R&D expenses increasing by 45.4% year-over-year. The company ended the year with a strong liquidity position, although cash and cash equivalents decreased due to acquisition activities.

Axon Enterprise, Inc. (AXON) has filed an 8-K report detailing the conclusion of privately negotiated exchange transactions involving its 0.50% Convertible Senior Notes due 2027. The company successfully exchanged approximately $407.5 million in aggregate principal amount of these notes for a combination of cash and newly issued shares of Axon's common stock. This transaction aims to reduce outstanding convertible debt and modify the company's capital structure.

Axon Enterprise, Inc. (AXON) has announced the successful closing of its private offering of $1,000.0 million in 6.125% senior notes due 2030 and $750.0 million in 6.250% senior notes due 2033. This $1.75 billion in aggregate principal amount of new debt, issued under separate indentures, is intended for general corporate purposes. Potential uses include repurchasing or redeeming existing convertible notes, funding growth initiatives, and supporting strategic acquisitions or investments in new technologies. Concurrently, Axon amended its existing credit agreement, increasing its revolving credit facility by $100 million to $300 million (with an option for further increase) and extending the maturity date to March 11, 2030. These actions strengthen Axon's financial flexibility and capital structure, providing resources for continued expansion and strategic opportunities.

Axon Enterprise, Inc. (AXON) announced on March 7, 2025, a significant transaction involving its 0.50% convertible senior notes due 2027. The company entered into private agreements with certain noteholders to exchange approximately $407.5 million in aggregate principal amount of these notes. The exchange consideration will comprise cash and shares of Axon's common stock. This move is expected to reduce the outstanding principal of these notes to approximately $282.5 million upon closing, anticipated around March 13, 2025. An estimated 1.0 million shares of common stock are expected to be issued in this exchange, based on the closing price of $499.31 on March 6, 2025, and a volume-weighted average price calculation over a specified period. Investors should note that the noteholders who have hedged their equity exposure may unwind these positions, potentially leading to substantial buying activity in Axon's common stock. This could significantly impact the stock's market price, though the exact magnitude and effect are unpredictable. The shares issued will be unregistered, relying on an exemption under Section 4(a)(2) of the Securities Act, as holders are expected to be accredited and qualified institutional buyers.

Axon Enterprise, Inc. (AXON) announced its intention to offer $1,500.0 million in aggregate principal amount of senior notes, split between 2030 and 2033 maturities. This offering is being conducted as a private placement to qualified institutional buyers and non-U.S. persons, exempt from standard registration requirements. The proceeds from this note offering are expected to be utilized in conjunction with an amendment to the company's existing credit agreement. In parallel with the note offering, Axon plans to amend its credit agreement to enhance its financial flexibility. Key changes include an increase in the revolving credit facility by $100.0 million to $300.0 million, with an option for a further $100.0 million increase. The availability for letters of credit will also rise by $20.0 million to $50.0 million. Additionally, the maturity date of the credit agreement will be extended to five years from the Amendment's closing date, subject to certain conditions related to outstanding convertible notes. These actions suggest proactive capital management and a strategic approach to funding future growth and operational needs.

Axon Enterprise, Inc. (AXON) reported a strong year of revenue growth, with net sales reaching $2.1 billion, a 33.4% increase compared to the prior year. This growth was driven by robust demand across both its TASER and Software and Sensors segments, with particular strength in TASER devices (especially the new TASER 10) and Axon Evidence cloud services. The company experienced a significant increase in stock-based compensation expenses, which impacted gross margins, but adjusted gross margins improved due to a higher mix of high-margin cloud services and cost-optimization initiatives. Despite a notable increase in operating expenses, primarily related to salaries, benefits, and stock-based compensation, Axon reported a substantial net income of $377.0 million, bolstered by gains on strategic investments. The company also announced a planned reorganization of its reporting segments into "Connected Devices" and "Software & Services" to better reflect its evolving business structure. However, the report disclosed a material weakness in internal controls related to revenue recognition, which management is actively addressing. From an investor perspective, the continued strong top-line growth is a positive indicator, showcasing the sustained demand for Axon's integrated public safety solutions. The strategic acquisitions of Fusus and Dedrone in 2024 demonstrate the company's commitment to expanding its ecosystem and technological capabilities. Investors should monitor the progress of the material weakness remediation and the impact of increasing stock-based compensation on profitability. The company's robust cash flow from operations and significant cash and investment balances provide a solid foundation for future growth and strategic investments, while the ongoing expansion into international markets presents further growth opportunities.

Axon Enterprise, Inc. (AXON) has filed an 8-K report on February 25, 2025, to disclose its financial results for the fourth quarter and full fiscal year ended December 31, 2024. This filing primarily references a shareholder letter (Exhibit 99.1) which contains the detailed financial performance data. Investors should refer to this attached letter for a comprehensive understanding of the company's revenue, profitability, and any forward-looking statements or strategic updates provided by management for the period. The significance of this 8-K lies in its role as the official vehicle for disseminating Axon's latest financial performance. While the 8-K itself is brief, it directs stakeholders to the shareholder letter for critical insights into the company's operational and financial health. This includes an overview of the company's performance against expectations, potential growth drivers, and any challenges or opportunities anticipated by Axon's leadership.

Axon Enterprise, Inc. reported robust revenue growth for the third quarter and first nine months of 2024, with total net sales reaching $544.3 million and $1.5 billion respectively. This represents significant year-over-year increases of 31.7% and 33.4%, driven by strong performance in both the TASER and Software & Sensors segments. The company saw particular strength in TASER devices and cartridges, alongside continued growth in its cloud-based Axon Evidence and services. Despite the revenue surge, income from operations decreased year-over-year for both periods, primarily due to a substantial increase in operating expenses, notably higher stock-based compensation and R&D investments. Financially, Axon ended the quarter with a strong liquidity position, holding $695.1 million in cash and cash equivalents. The company also reported a significant increase in goodwill and intangible assets, largely due to the acquisition of Fusus, LLC. Additionally, Axon announced a major acquisition of Dedrone Holdings, Inc. in October 2024, signaling continued strategic expansion. While profitability metrics were impacted by increased expenses, the overall financial health and growth trajectory remain positive, supported by a substantial remaining performance obligation backlog of $7.7 billion.

Axon Enterprise, Inc. (AXON) has filed an 8-K report on November 7, 2024, to announce its third-quarter financial results for the period ending September 30, 2024. The filing includes a shareholder letter detailing these results, accompanied by comprehensive financial statements, segment reporting, balance sheets, cash flow information, and statistical measures. Notably, the report provides reconciliations between GAAP and non-GAAP financial measures, offering investors a clearer view of the company's operational performance beyond standard accounting principles. This report is crucial for understanding Axon's recent financial trajectory and operational highlights.

Axon Enterprise, Inc. (AXON) reported strong revenue growth in its Form 10-Q for the period ending June 30, 2024. Total net sales increased by 34.6% year-over-year to $504.1 million for the quarter, and by 34.4% to $964.8 million for the six-month period. This growth was driven by both the TASER segment (up 27.6% quarterly) and the Software and Sensors segment (up 39.5% quarterly), with notable increases in TASER devices, cartridges, and Axon Body Cameras and Accessories. The company also saw a significant rise in its recurring revenue from cloud services. Despite robust top-line growth, operating income decreased year-over-year for both the quarter ($32.9 million vs. $40.3 million) and the six-month period ($49.2 million vs. $56.9 million). This was primarily attributed to increased operating expenses, particularly higher stock-based compensation and R&D investments, as well as amortization of acquired intangibles. The company's gross margin percentage also saw a slight decrease, impacted by these factors, although adjusted gross margin (excluding stock-based compensation and amortization) showed improvement, particularly in the Software and Sensors segment. Significant strategic investments and business acquisitions, including the acquisition of Fusus and the pending acquisition of Dedrone, are noted as key drivers of future growth and integration efforts.

Axon Enterprise, Inc. (AXON) has filed an 8-K on August 6, 2024, to announce its second quarter financial results for the period ended June 30, 2024. The filing primarily incorporates by reference a shareholder letter containing detailed financial performance information, including statements of operations, balance sheets, cash flow, segment reporting, statistical measures, and reconciliations of GAAP to non-GAAP financial measures. Investors should refer to the attached Exhibit 99.1 for the full suite of financial data and management's commentary on the quarter's performance. While this 8-K serves as notification of the earnings release, the detailed operational and financial insights, including specific revenue figures, profitability metrics, and forward-looking statements, are contained within the accompanying shareholder letter. This letter will be crucial for understanding Axon's current financial health, growth drivers, and any significant developments that may impact future performance. Investors are encouraged to review Exhibit 99.1 thoroughly for a comprehensive understanding of Axon's Q2 2024 results.

Axon Enterprise, Inc. (AXON) filed an 8-K on May 13, 2024, detailing the outcomes of its 2024 Annual Meeting of Shareholders held on May 10, 2024. The primary focus of the filing is the shareholder approval of amendments to key equity incentive plans, including the Amended and Restated 2022 Stock Incentive Plan, the 2024 eXponential Stock Plan (2024 Employee XSP), and a specific CEO Performance Award for Patrick W. Smith. These approvals are crucial for the company's ability to grant future equity-based compensation to its employees and officers, ensuring continued alignment of interests and talent retention.

Axon Enterprise, Inc. has filed an 8-K report detailing the establishment of a new "at the market" equity offering program. This program allows Axon to sell up to 1,954,450 shares of its common stock, which were unsold from a previous offering that expired on April 20, 2024. The shares will be sold through J.P. Morgan Securities LLC as the agent, with Axon retaining the discretion to determine the timing and amounts of any sales. The company intends to use the net proceeds for general corporate purposes, including funding tax obligations related to stock compensation, supporting growth initiatives, and potential acquisitions. This filing indicates Axon's strategy to potentially raise capital through the sale of existing registered shares. Investors should note that the company is not obligated to sell any shares and can suspend or terminate the program at any time. The agreement with the agent includes a commission of up to 2% on gross sales. The overall capacity for this offering is modest relative to Axon's market capitalization, suggesting it's a flexible tool for opportunistic capital raising rather than a significant financing event.

Axon Enterprise, Inc. reported strong revenue growth in the first quarter of 2024, with net sales increasing by 34.3% year-over-year to $460.7 million. This growth was driven by robust performance in both the Software and Sensors segment (up 35.1%) and the TASER segment (up 33.1%), with notable contributions from Axon Evidence and Cloud Services, Axon Body Cameras and Accessories, and TASER devices. Despite significant revenue growth, operating income slightly decreased to $16.3 million from $16.6 million in the prior year, primarily due to increased operating expenses, including higher stock-based compensation and professional services related to acquisitions. However, net income saw a substantial increase of 195.1% to $133.2 million, largely influenced by significant gains from strategic investments and the Fusus acquisition. The company also announced a definitive agreement to acquire Dedrone Holdings, Inc. for approximately $400 million, further expanding its offerings in airspace security.

Axon Enterprise, Inc. (AXON) has filed an 8-K on May 6, 2024, to report its financial results for the first quarter ended March 31, 2024, via a shareholder letter. The filing incorporates by reference a detailed shareholder letter, including audited consolidated statements of operations, segment reporting, balance sheets, cash flow information, statistical measures, and GAAP to non-GAAP reconciliations, attached as Exhibit 99.1. Investors should refer to Exhibit 99.1 for the comprehensive financial performance details of the first quarter. While this 8-K filing primarily serves to present these results, it does not contain new operational updates or strategic disclosures beyond what is provided in the shareholder letter. The information is furnished and not deemed filed for purposes of Section 18 of the Securities Exchange Act.

Axon Enterprise, Inc. (AXON) filed a Form 8-K on March 5, 2024, primarily to announce a change in its Board of Directors. Dr. Mark W. Kroll has resigned from the Board, with his resignation effective as of the Company's 2024 Annual Meeting of Shareholders. The company expressed gratitude for his contributions to its growth and progress during his tenure. This filing does not indicate any immediate operational or financial changes. Investors should note that board composition changes, while important for governance, do not typically signal a shift in the company's strategic direction or financial performance unless accompanied by other information. The company's statement thanks Dr. Kroll for his deep commitment and leadership, suggesting a respectful and amicable departure. Investors should monitor future filings for any potential updates regarding board appointments or strategic shifts.

Axon Enterprise, Inc. reported strong revenue growth of 31.4% for the year ended December 31, 2023, reaching $1.6 billion. This growth was driven by both the TASER segment (up 15.2%) and the Software and Sensors segment (up 44.4%), with significant contributions from new product introductions like TASER 10 and Axon Body 4. The company's financial strategy emphasizes highly recurring, profitable businesses, reflected in the robust growth of its Axon Evidence cloud services, which saw a 52.2% increase in revenue. The company's commitment to innovation and strategic growth is evident in its continued investment in R&D, which increased by 29.9% year-over-year. Despite increased operating expenses, particularly in salaries and stock-based compensation, Axon demonstrated improved profitability, with income from operations increasing by 66.0% to $154.8 million. The company also highlighted substantial future contracted revenue of $7.1 billion as of year-end 2023, indicating a strong revenue visibility for the coming years.

Axon Enterprise, Inc. filed an 8-K on February 27, 2024, primarily to announce financial results for the fourth quarter and fiscal year ended December 31, 2023, through a shareholder letter. While the specific financial figures are detailed in an attached exhibit, this filing signals that Axon is providing an update on its performance. Investors should refer to the shareholder letter for comprehensive details on revenue, profitability, and any forward-looking statements regarding the company's outlook. The filing also includes a significant change in the company's independent auditor, appointing PricewaterhouseCoopers LLP effective after the upcoming 10-K filing, and dismissing Grant Thornton LLP after a long tenure. The change in auditors is a noteworthy event for investors, indicating a potential shift in audit approach or oversight. The report explicitly states that the decision to switch auditors was made by the Audit Committee and that there were no disagreements with Grant Thornton leading to their dismissal, though a material weakness in internal controls was noted related to revenue recognition. Investors should monitor future financial reports for any impact of the new auditor on financial reporting and internal control remediation efforts.

Axon Enterprise, Inc. (AXON) filed an 8-K on December 21, 2023, to report amendments to its corporate bylaws, effective immediately as of December 20, 2023. These changes, stemming from a periodic review of governance documents, introduce significant updates primarily affecting stockholder rights and meeting procedures. The most notable addition is the implementation of "Proxy Access Provisions," allowing a qualifying group of stockholders to nominate directors and include them in the company's proxy materials, subject to specific ownership thresholds and holding periods. Further amendments clarify the timelines for stockholder nominations and proposals, incorporate requirements related to universal proxy cards as mandated by the SEC, and refine the information disclosure needed from stockholders making nominations. The company has also updated its bylaws concerning proxy card colors, meeting adjournments, and has established exclusive forum selection clauses for disputes, designating Delaware Chancery Court for certain state law matters and U.S. federal district courts for Securities Act of 1933 claims. Investors should note these changes as they impact corporate governance and shareholder engagement processes.

Axon Enterprise, Inc. (AXON) has filed an 8-K report detailing significant changes to its Chief Executive Officer's (CEO) compensation and employment terms, effective December 8, 2023. The company has entered into a new Employment Agreement with CEO Patrick W. Smith, outlining his continued leadership through December 31, 2030, with provisions for at-will employment thereafter. Notably, the agreement sets Mr. Smith's base salary at minimum wage, with no increases until 2031, and he will not be eligible for annual bonuses or equity awards during this period, except for a substantial one-time grant. This filing also addresses a previously granted stock option award and a subsequent letter agreement. The company has waived a holding period on shares valued at approximately $25 million, allowing Mr. Smith to contribute them to a charitable fund. Investors should note the specific financial commitments required from Mr. Smith under both agreements if he terminates his employment under certain conditions. The new employment terms, particularly the unusual compensation structure for the CEO, suggest a strategic focus on retaining and incentivizing other key employees.

Axon Enterprise, Inc. (AXON) reported strong revenue growth in the third quarter and first nine months of 2023, driven by increases in both its TASER and Software and Sensors segments. Net sales for the quarter reached $413.6 million, a 32.7% increase year-over-year, while the nine-month total reached $1.1 billion, up 32.5%. This growth was fueled by robust demand for Axon Evidence and cloud services, Axon Body Cameras, and Axon Fleet Systems, alongside steady performance in TASER devices and cartridges. The company demonstrated improved operational efficiency, with income from operations rising significantly to $55.1 million for the quarter and $112.0 million for the nine months, compared to the prior year periods. While gross margin percentage saw a slight dip due to the ramp-up of new products like TASER 10 and increased costs in certain hardware and professional services, the overall dollar increase in gross margin was substantial. The company also managed its operating expenses effectively, with SG&A and R&D expenses growing at a slower pace than revenue, indicating good cost control as the company scales.

Axon Enterprise, Inc. (AXON) filed an 8-K on November 7, 2023, primarily to report its third-quarter 2023 financial results via a shareholder letter. This filing provides investors with an update on the company's operational and financial performance for the period. The details of these results, including financial statements and reconciliations, are furnished as an exhibit to this report, allowing stakeholders to assess Axon's recent business trajectory.

This Form 8-K/A filing from Axon Enterprise, Inc. (AXON) serves as an amendment to a prior report, primarily to disclose updated compensation arrangements for two key executives, Joshua M. Isner (President) and Brittany Bagley (Chief Operating Officer and Chief Financial Officer), following their recent promotions. The Compensation Committee of the Board of Directors approved these revisions, aiming to align executive pay with market benchmarks, generally around the 50th percentile of peer data. Key adjustments include revised base salaries and annual target cash incentive compensation for Mr. Isner, along with significant grants of restricted stock units (RSUs) for both executives. These RSU grants are designed to incentivize long-term performance and retention, with vesting schedules extending over several years. Investors should note these compensation adjustments reflect the expanded responsibilities of these critical leadership roles and the company's strategy to reward and retain top talent.

This 8-K/A filing from Axon Enterprise, Inc. (AXON) serves as an amendment to a previous report, specifically to clarify the frequency of shareholder advisory votes on executive compensation. The Board of Directors has officially determined that these "say-on-pay" advisory votes will be held annually, aligning with the outcome of shareholder Proposal No. 3 from the May 31, 2023 Annual Meeting. This decision directly responds to shareholder input and formalizes the annual advisory vote on executive compensation. Investors should note that this filing does not introduce new financial information or material business updates; its sole purpose is to communicate the Board's decision regarding the frequency of this specific shareholder vote, demonstrating responsiveness to shareholder sentiment on executive pay.

This 8-K filing from Axon Enterprise, Inc. (AXON), dated August 8, 2023, announces the release of the company's second quarter 2023 financial results via a shareholder letter. While the 8-K itself is brief, it directs investors to Exhibit 99.1 for detailed financial performance, including statements of operations, segment reporting, balance sheets, cash flow information, statistical measures, and reconciliations of GAAP to non-GAAP financial measures. Investors should consult this attached exhibit for a comprehensive understanding of Axon's performance during the second quarter.

Axon Enterprise, Inc. (AXON) reported strong top-line growth in its second quarter of 2023, with net sales increasing by 31.2% year-over-year to $374.6 million. This growth was driven by a significant increase in both the TASER and Software and Sensors segments. The TASER segment saw a 13.9% rise, largely due to the new TASER 10 device, while the Software and Sensors segment experienced robust growth of 46.8%, fueled by strong demand for Axon Evidence and Cloud Services and Axon Fleet Systems. Despite the revenue surge, net income saw a substantial decrease to $12.4 million from $51.0 million in the prior year's quarter. This decline was primarily due to a significant non-cash unrealized impairment loss of $71.9 million related to a strategic investment. However, excluding this impairment, the company's operational performance showed resilience, with income from operations more than doubling year-over-year. The company also highlighted substantial future contracted revenue of $5.2 billion, indicating strong future revenue potential.

Axon Enterprise, Inc. (AXON) announced significant leadership changes via an 8-K filing on July 5, 2023, detailing events from June 28, 2023. The company promoted Joshua M. Isner to President, a role where he will continue to focus on execution, growth, and global expansion, reporting to CEO Rick Smith. Isner's extensive experience within Axon, including his prior role as COO and Chief Revenue Officer, positions him to drive top-line performance and explore new markets and product categories. Furthermore, Brittany Bagley has been appointed as Chief Operating Officer and Chief Financial Officer. Bagley, who joined Axon in September 2022 as CFO, will now be responsible for integrating financial functions with operations, including manufacturing and supply chain, aiming for enhanced operational efficiency and financial strength. Her background as CFO of Sonos and experience at KKR and Goldman Sachs brings valuable financial and operational expertise to this expanded role. Both appointments are effective immediately, with no immediate changes to their compensation, though a review is pending.

This 8-K filing from Axon Enterprise, Inc. details the outcomes of its Annual Meeting of Shareholders held on May 31, 2023. A significant majority of outstanding shares were represented, indicating strong shareholder engagement. Key to investors, all incumbent directors were overwhelmingly re-elected, and the advisory "Say-on-Pay" proposal regarding executive compensation received substantial support, as did the ratification of Grant Thornton LLP as the company's independent auditor for fiscal year 2023. Notably, the company elected not to submit Proposal No. 5, concerning a "2023 CEO Performance Award," to a vote, citing that withdrawal was in the best interest of the company. Furthermore, a shareholder proposal to discontinue the development of a non-lethal TASER drone system was decisively defeated, signaling continued shareholder confidence in the company's strategic direction and product development. In summary, the meeting reflects robust shareholder support for the board of directors, executive compensation practices, auditor appointment, and the company's overall business strategy, including its product development initiatives. The withdrawal of the CEO performance award proposal and the rejection of the shareholder proposal on drone development are important signals regarding internal decision-making and shareholder sentiment on strategic matters.

Axon Enterprise, Inc. (AXON) filed an 8-K on May 9, 2023, to announce its first-quarter 2023 financial results. The report primarily serves as a vehicle to furnish a shareholder letter detailing these results, along with accompanying unaudited financial statements and reconciliations. Investors should refer to the attached Exhibit 99.1 for the comprehensive details of the company's performance and financial condition for the period ended March 31, 2023. While this 8-K filing itself does not contain the specific financial figures, it directs investors to the detailed shareholder letter and financial statements where such information is disclosed. Key metrics, operational performance, and forward-looking statements, if any, would be found within the provided exhibits, offering insights into Axon's business trajectory and its financial health.

Axon Enterprise, Inc. reported strong revenue growth in the first quarter of 2023, with total net sales increasing by 33.8% year-over-year to $343.0 million. This growth was driven by robust performance in both the Software and Sensors segment (+46.9%) and the TASER segment (+17.4%). The Software and Sensors segment, in particular, saw significant boosts from Axon Evidence and Cloud Services, as well as Axon Fleet Systems. Despite the impressive revenue increase, net income decreased to $45.1 million from $54.9 million in the prior year, primarily due to a notable increase in operating expenses, particularly in sales, general, and administrative (SG&A) and research and development (R&D), which rose by 29.3% and 46.5% respectively. This increase in expenses was largely attributed to higher headcount, increased stock-based compensation, and higher salaries and benefits. The company ended the quarter with a healthy cash and cash equivalents balance of $263.4 million, though this was a decrease from the prior quarter. Axon also highlighted its substantial remaining performance obligations of approximately $4.8 billion, providing visibility into future contracted revenues. While the company faces ongoing risks related to supply chain, litigation, and macroeconomic conditions, its strategic investments in cloud-based solutions and continued expansion in the public safety technology market position it for sustained growth.